AzTrials
AzTrials

Pressure UlcerNCT03725787

Pressure Ulcer Incidence Cat. II+ on a Static Air Mattress: a Multicenter Cohort Study in Nursing Home Residents at Risk

A study testing CuroCell S.A.M. ® pro mattress in people with Pressure Ulcer and Pressure Injury, run by University Ghent at 8 sites in Belgium.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Pressure Ulcers are a serious and common problem for residents admitted to long-term care facilities and community care patients. They represent a major burden to patients, carers and the Healthcare system, affecting approximately 1 in 20 community patients. Read more about this study

Who is it for?
Ages 65 years and olderHealthy volunteers can take part
Conditions the study is for
Pressure Ulcer, Pressure Injury, Pressure Sore
What is being tested?
CuroCell S.A.M. ® pro mattress
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
180 participants
Where
8 sitesBelgium
Study dates
4 Mar 2018to 6 Oct 2020
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 65 years and older
  • All sexes
  • Healthy volunteers accepted
  • Older adult

Who may be able to join

  • At risk of pressure ulcer development based on a Braden score ≤ 17
  • Bedbound or chair bound
  • Aged ≥ 65

Who cannot join

  • Short-stay residents (expected length of stay ≤14 days)
  • End of life care
  • Medical contraindication for patient repositioning/turning
  • Pressure ulcer Cat. II+ present on initial evaluation

Trial locations and contacts

8 sites in 1 country.

8 sites in 1 country

Belgium8 sites
  • WZC Sint-Vincentius

    Deinze, Oost-Vlaanderen, 9800

  • WZC Sint-Jozef

    Ghent, Oost-Vlaanderen, 9000

  • WZC Sint-Vincentius

    Kaprijke, Oost-Vlaanderen, 9970

  • WZC Sint-Rafaël

    Liedekerke, Vlaams-Brabant, 1770

  • WZC Brugse Vaart

    Mariakerke, Oost-Vlaanderen, 9030

  • Provinciaal Zorgcentrum Lemberge

    Merelbeke, Oost-Vlaanderen, 9820

  • WZC Onderdale

    Ursel, Oost-Vlaanderen, 9910

  • Residentie Vroonstalle

    Wondelgem, Oost-Vlaanderen, 9032

Other trials in Belgium

About this study

Official title: Pressure Ulcer Incidence Cat. II+ on the CuroCell SAM® PRO Static Air Mattress: a Multicenter Cohort Study in Nursing Home Residents at Risk

Pressure Ulcers are a serious and common problem for residents admitted to long-term care facilities and community care patients. They represent a major burden to patients, carers and the Healthcare system, affecting approximately 1 in 20 community patients. International guidelines recommend the use of pressure redistribution support surfaces, systematic patient repositioning and preventive skin care to prevent pressure ulcers.

It has been acknowledged that a significant proportion of pressure ulcers are avoidable. The prevalence of pressure ulcers is 1 of the 4 common harms recorded in the UK NHS Safety Thermometer, a local improvement tool for measuring, monitoring and analyzing patient harms across a range of settings, including nursing homes, community nursing and hospitals on a monthly basis.

Read more

Static or reactive overlay mattresses are an example of a low-tech constant low-pressure support. Static air mattresses maintain a continuous low air pressure that exerts a pressure redistributing effect. Serraes and Beeckman found a pressure ulcer incidence of 5.1% in patients placed on static air support (mattress overlay, heel wedge and seat cushion) in a high risk population in a nursing home setting in Belgium.

The CuroCell SAM PRO (Care of Sweden AB) is a static air mattress overlay system used as prevent and treat pressure ulcers (up to category 3) and for pain therapy. The aim of current study is to measure pressure ulcer incidence on the CuroCell Sam PRO static air mattress in nursing home residents at risk for pressure ulcer development over a 30-day period in Belgium.

Being tested
CuroCell S.A.M. ® pro mattress
Keywords
Static air support surface, Support device, Elderly, Prevention
Medical subject headings
Pressure Ulcer

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • CuroCell S.A.M. ® pro mattressDevice

    During 30 days, participants will use the static air mattress.

Study groups in NCT03725787
Study groupRoleWhat they receive
CuroCell S.A.M. ® pro mattressExperimentalMattresses of eligible participants will be replaced by a static air pressure redistribution mattress (CuroCell S.A.M. ® Pro).
Receives: Device: CuroCell S.A.M. ® pro mattress

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Pressure ulcer incidence (Cat. II+), (NPUAP classification system)

    Development of at least 1 pressure ulcer Cat. II+ during study period, not associated with the use of medical devices

    Measured: 30 days

Secondary outcomes (2)
  1. Incidence rate of Cat. I pressure ulcers, (NPUAP classification system)

    Development of at least 1 pressure ulcer Cat. I during study period, not associated with the use of medical devices

    Measured: 30 days

  2. Comfort of participants (self developed questionnaire)

    A quantitative approach to obtain insight in residents' experiences and perceptions of comfort by using a questionnaire

    Measured: 30 days

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted31 Oct 2018
  2. Study start4 Mar 2018
  3. Primary completion6 Feb 2019
  4. Study completion6 Oct 2020

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
180 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03725787
Sponsor's protocol ID
EC/2018/0091
Other IDs
B670201835095
Status last verified
Oct 2018
First submitted
25 Oct 2018
Last updated
6 May 2021
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Publications

  • National Pressure Ulcer Advisory Panel, European Pressure Ulcer Advisory Panel and Pan Pacific Pressure Injury Alliance. Prevention and Treatment of Pressure Ulcers: Quick Reference Guide. Emily Haesler (Ed.). Cambridge Media: Osborne Park, Western Australia; 201.

  • Levy A, Kopplin K; BS; Gefen A. Computer simulations of efficacy of air-cell-based cushions in protecting against reoccurrence of pressure ulcers. J Rehabil Res Dev. 2014;51(8):1297-319. doi: 10.1682/JRRD.2014.02.0048.

    PubMed 25625315
  • Brown S, Smith IL, Brown JM, Hulme C, McGinnis E, Stubbs N, Nelson EA, Muir D, Rutherford C, Walker K, Henderson V, Wilson L, Gilberts R, Collier H, Fernandez C, Hartley S, Bhogal M, Coleman S, Nixon JE. Pressure RElieving Support SUrfaces: a Randomised Evaluation 2 (PRESSURE 2): study protocol for a randomised controlled trial. Trials. 2016 Dec 20;17(1):604. doi: 10.1186/s13063-016-1703-8.

    PubMed 27993145

Questions about this trial

What is this clinical trial studying?

A study testing CuroCell S.A.M. ® pro mattress in people with Pressure Ulcer and Pressure Injury, run by University Ghent at 8 sites in Belgium.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 6 May 2021. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 8 sites in Belgium. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Pressure ulcer incidence (Cat. II+), (NPUAP classification system) (time frame: 30 days). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03725787, which also lists 3 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 May 2021.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in